Growth Metrics

Innoviva (INVA) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $21.6 million.

  • Innoviva's Accumulated Expenses rose 2277.4% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year increase of 2277.4%. This contributed to the annual value of $30.0 million for FY2024, which is 5229.46% up from last year.
  • Innoviva's Accumulated Expenses amounted to $21.6 million in Q3 2025, which was up 2277.4% from $38.0 million recorded in Q2 2025.
  • Innoviva's Accumulated Expenses' 5-year high stood at $38.0 million during Q2 2025, with a 5-year trough of $1.7 million in Q1 2021.
  • Its 5-year average for Accumulated Expenses is $11.2 million, with a median of $5.2 million in 2023.
  • Per our database at Business Quant, Innoviva's Accumulated Expenses crashed by 2019.16% in 2023 and then soared by 79608.42% in 2025.
  • Innoviva's Accumulated Expenses (Quarter) stood at $4.2 million in 2021, then skyrocketed by 93.21% to $8.0 million in 2022, then skyrocketed by 145.55% to $19.7 million in 2023, then surged by 52.29% to $30.0 million in 2024, then fell by 27.97% to $21.6 million in 2025.
  • Its Accumulated Expenses was $21.6 million in Q3 2025, compared to $38.0 million in Q2 2025 and $30.7 million in Q1 2025.